Health
GSK shares slide after US health agency narrows scope of RSV shots
GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus
June 27, 2024Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus
June 27, 2024